misonidazole has been researched along with Vomiting in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, RJ; Levin, VA; Phillips, TL; VanRaalte, G; Wasserman, TH | 1 |
| Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J | 1 |
| Martin, WM; McDermott, BJ; Murphy, RF; Van den Berg, HW | 1 |
| Arnold, EP; Bailey, C; Burry, AF; Bydder, PV; Firth, LA; Gowland, S; Gray, AJ; Mcllroy, R | 1 |
| Phillips, TL; Stetz, J; Wasserman, TH | 1 |
| Gomer, CJ; Johnson, RJ; Lawrence, GA; Levin, VA; Marques, RA; Phillips, TL; Sadee, W; VanRaalte, G; Wasserman, TH | 1 |
| Beningo, KA; Elliott, WL; Heffner, TG; Leopold, WR; Sebolt-Leopold, JS; Stier, MA; Suto, MJ; Vincent, PW; Wiley, JN | 1 |
| Deacon, JM; Holliday, SB; Horwich, A; Peckham, MJ | 1 |
5 trial(s) available for misonidazole and Vomiting
| Article | Year |
|---|---|
Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Topics: Aged; Carcinoma, Squamous Cell; Double-Blind Method; Esophagitis; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Placebos; Pneumonia; Radiation Injuries; Radiotherapy Dosage; Random Allocation; Vomiting | 1983 |
A national trial on the treatment of invasive bladder cancer.
Topics: Carcinoma; Clinical Trials as Topic; Humans; Misonidazole; Nausea; Neoplasm Staging; New Zealand; Nitroimidazoles; Urinary Bladder Neoplasms; Vomiting | 1981 |
Radiation Therapy Oncology Group clinical trials with misonidazole.
Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Administration Schedule; Glioma; Head and Neck Neoplasms; Humans; Misonidazole; Nausea; Nervous System Diseases; Nitroimidazoles; Radiotherapy Dosage; Random Allocation; Vomiting | 1981 |
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer.
Topics: Administration, Oral; Drug Administration Schedule; Drug Evaluation; Humans; Misonidazole; Nausea; Neoplasms; Nitroimidazoles; Peripheral Nervous System Diseases; Sensation; Vomiting | 1979 |
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069.
Topics: Adult; Aged; Clinical Trials as Topic; Humans; Kinetics; Middle Aged; Misonidazole; Nausea; Radiation-Sensitizing Agents; Vomiting | 1986 |
3 other study(ies) available for misonidazole and Vomiting
| Article | Year |
|---|---|
Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Peripheral Nervous System Diseases; Vomiting | 1981 |
Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans.
Topics: Adult; Aged; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Kinetics; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Time Factors; Vomiting | 1983 |
Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agents.
Topics: Animals; Antiemetics; Dogs; Drug Evaluation; Imidazoles; Mice; Misonidazole; Nitroimidazoles; Ondansetron; Radiation-Sensitizing Agents; Vomiting | 1992 |